David Lebwohl
EVP, Chief Medical Officer, Intellia Therapeutics, Inc.
Bought, 12 months
$0.0M
Sold, 12 months
$0.1M
Companies
1
Latest trade
Jan 5, 2026
Companies
Intellia Therapeutics, Inc.EVP, Chief Medical Officer −$0.1M
Trades
Open-market trades from SEC Form 4 only: no grants, option exercises or gifts. People are matched by the name on their filings, so two people with the same name share this page. For information only — not investment advice.